|Articles|July 1, 2020
- Pharmaceutical Executive-07-01-2020
- Volume 40
- Issue 7
Pharmaceutical Executive, July 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Will COVID-19 Usher in a New Era in Pharma Marketing?over 5 years ago
Is Drug Production Heading Back to Europe From Abroad?over 5 years ago
Central Focus: Targeting Unmet Need in CNSover 5 years ago
Will the Industry Rise to the Occasion?over 5 years ago
How Oncologists are Coping with COVID-19over 5 years ago
Virtual Hiring of the C-Suiteover 5 years ago
Culture and Compliance: Building a Culture of Business Ethicsover 5 years ago
Fauci: Industry Will ‘Walk Away’ From COVID Price Controlsover 5 years ago
A Sustainable Response to COVID-19over 5 years ago
Enterprise Leadership: Is Compliance Ripe for Disruption?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
Novavax Enters $530 Million License Agreement with Pfizer for Vaccine Development
4
Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics
5
